Indications and uses
• helps prevent sunburn • if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30
- Manufacturer
- Extra Shade, LLC | Columbia Cosmetics Manufacturing, Inc.
- Effective date
- 2025-03-18
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- full-release
- Hydrated at
- 2026-06-01 00:57:23
Label at a glance#
ProductEXTRASHADE Daily Defense Hydrating Sunscreen SPF 30
Active ingredientAVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE
Label structure17 sections
Dosage and administration
• apply liberally 15 minutes before sun exposure • reapply: • after 80 minutes of swimming or sweating • immediately after towel drying • at least every 2 hours • Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including: • limit tim...
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredients
Active ingredients Purpose
Avobenzone 3.0%
Octinoxate 7.5%Sunscreen } Sunscreen
Octisalate 5.0%
Oxybenzone 4.0%
Uses
• helps prevent sunburn
• if used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
For external use only
Do not use
on damaged or broken skin
When using this product
keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor
if rash occurs
Keep out of reach of children
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
• apply liberally 15 minutes before sun exposure
• reapply:
• after 80 minutes of swimming or sweating
• immediately after towel drying
• at least every 2 hours
• Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF of 15 or higher and other sun protection measures including:
• limit time in the sun, especially from 10 a.m. – 2 p.m.
• wear long-sleeve shirts, pants, hats, and sunglasses.
Inactive ingredients
Water (Aqua), Glyceryl Stearate, Ethylhexyl Methoxycrylene, Glycerin, Jojoba Esters, Dimethicone, VP/Eicosene Copolymer, Cetearyl Alcohol, Cetyl Dimethicone, Potassium Cetyl Phosphate, PEG-100 Stearate, Phenoxyethanol, Caprylyl Glycol, Ethylhexylglycerin, Tocopheryl Acetate, Tertrahexyldecyl Ascorbate, Sodium Hyaluronate, Hydroxyethylcellulose, Hexylene Glycol, Punica Granatum Quillaja (Pomegranate) Extract, Cocos Nucifera (Coconut) Extract, Hedychium Coronarium Root (White Ginger) Extract, Actinidia Chinensis (Kiwi Fruit) Extract, Hibiscus Rosa Sinensis Extract, Passion Flora Incarnata (Passion Flower) Extract, Plantago Major Leaf (Plantain) Extract, Saponaria Bark (Soap Bark) Extract
Other information
• protect this product from excessive heat and direct sun
Questions or comments?
Call toll free 1-888-637-5724
Purpose
Sunscreen
Description
EXTRASHADE SUN PROTECTION FOR RICH COMPLEXIONS BROAD SPECTRUM SPF 30
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
EXTRASHADE SUN PROTECTION FOR RICH COMPLEXIONS BROAD SPECTRUM SPF 30 DAILY DEFENSE HYDRATING SUNSCREEN LOTION WATER RESISTANT (80 MINUTES) • PABA FREE FRAGRANCE FREE • OIL FREE • DYE FREE FACE AND BODY PROTECTION FOR ACTIVE LIFESTYLE 4.0 Fl Oz (120ml)
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
Drug Facts
Extra Shade 1
Extra Shade 2
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 42338-001-04 | 2025-03-18 | C162847 | 48780-1 | 9d75b9d0-4843-f424-e053-dadaa90a57ce | EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30 (4 fl oz / 120 ml) |
| 42338-001-04 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-4843-f424-e053-dadaa90a57ce | EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30 (4 fl oz / 120 ml) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42338-001-04 | EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30 | 1 in 1 CARTON | LOTION | 1 | 4 | |
| 42338-001-04 | EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30 | 120 mL in 1 BOTTLE | LOTION | 120 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 42338-001 | EXTRASHADE DAILY DEFENSE HYDRATING SUNSCREEN SPF 30 (AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE) LOTION [EXTRA SHADE, LLC] | 4 | Current NDC, Legacy NDC, 2 package rows | 20250321_d197dfe3-c754-4a3d-9edd-335f3fce105c.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| AVOBENZONE | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE INGREDIENT | 4Y5P7MUD51 | 1 | |
| OCTISALATE | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| OXYBENZONE | ACTIVE INGREDIENT | 95OOS7VE0Y | 1 | |
| AVOBENZONE | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| OCTINOXATE | ACTIVE MOIETY | 4Y5P7MUD51 | 1 | |
| OCTISALATE | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| OXYBENZONE | ACTIVE MOIETY | 95OOS7VE0Y | 1 | |
| ALPHA-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| CAPRYLYL GLYCOL | INACTIVE INGREDIENT | 00YIU5438U | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| COCONUT | INACTIVE INGREDIENT | 3RT3536DHY | 1 | |
| DIMETHICONE | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| ETHYLHEXYLGLYCERIN | INACTIVE INGREDIENT | 147D247K3P | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERYL MONOSTEARATE | INACTIVE INGREDIENT | 230OU9XXE4 | 1 | |
| HEDYCHIUM CORONARIUM ROOT | INACTIVE INGREDIENT | 92A6N0IQN9 | 1 | |
| HEXYLENE GLYCOL | INACTIVE INGREDIENT | KEH0A3F75J | 1 | |
| HIBISCUS ROSA-SINENSIS FLOWERING TOP | INACTIVE INGREDIENT | X9SED65819 | 1 | |
| HYALURONATE SODIUM | INACTIVE INGREDIENT | YSE9PPT4TH | 1 | |
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | INACTIVE INGREDIENT | 8136Y38GY5 | 1 | |
| KIWI FRUIT | INACTIVE INGREDIENT | 71ES77LGJC | 1 | |
| PASSIFLORA EDULIS FLOWER | INACTIVE INGREDIENT | SY49TH8VUA | 1 | |
| PEG-100 STEARATE | INACTIVE INGREDIENT | YD01N1999R | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| PLANTAGO MAJOR LEAF | INACTIVE INGREDIENT | 7DC28K241X | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| SAPONARIA OFFICINALIS ROOT | INACTIVE INGREDIENT | RI2K1BMA8B | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30
- AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE
- POMEGRANATE
- WATER
- GLYCERYL MONOSTEARATE
- GLYCERIN
- DIMETHICONE
- CETOSTEARYL ALCOHOL
- POTASSIUM CETYL PHOSPHATE
- PEG-100 STEARATE
- PHENOXYETHANOL
- CAPRYLYL GLYCOL
- ETHYLHEXYLGLYCERIN
- .ALPHA.-TOCOPHEROL ACETATE, DL-
- HYALURONATE SODIUM
- HYDROXYETHYL CELLULOSE (2000 MPA.S AT 1%)
- HEXYLENE GLYCOL
- COCONUT
- HEDYCHIUM CORONARIUM ROOT
- HIBISCUS ROSA-SINENSIS FLOWER
- PASSIFLORA INCARNATA FRUIT
- PLANTAGO MAJOR LEAF
- QUILLAJA SAPONARIA BARK
- AVOBENZONE
- OCTINOXATE
- OCTISALATE
- OXYBENZONE
- EICOSYL POVIDONE
- HYDROGENATED JOJOBA OIL/JOJOBA OIL, RANDOMIZED (IODINE VALUE 57-61)
- ACTINIDIA CHINENSIS (KIWI) FRUIT
- ETHYLHEXYL METHOXYCRYLENE
- TETRAHEXYLDECYL ASCORBATE
- CETYL DIMETHICONE 45
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 42338-001 | 42338-001-04 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SYRUP / ORAL | 100 mg/5ml | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM, SOLUBLE / BUCCAL | 161 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SUSPENSION / ORAL | 1200 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | CREAM / TOPICAL | 385 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM / BUCCAL | 55 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | CAPSULE / ORAL | 20 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET / ORAL | 2 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, EXTENDED RELEASE / ORAL | 150 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, FILM COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LOTION / TOPICAL | 3990 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | SOLUTION / TOPICAL | 0.3 %w/w | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| HYALURONATE SODIUM | HYALURONATE SODIUM | YSE9PPT4TH | LOTION / TOPICAL | 0.01 %w/w | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | GEL / TOPICAL | 280 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | OINTMENT / TOPICAL | 12 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SYRUP / ORAL | 100 mg/5ml | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM / BUCCAL | 55 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | GEL / TOPICAL | 280 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | OINTMENT / TOPICAL | 12 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SOLUTION / ORAL | 1867 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| PEG-100 STEARATE | PEG-100 MONOSTEARATE | YD01N1999R | LOTION / TOPICAL | 1 %w/w | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET / ORAL | 2 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SUSPENSION / ORAL | 1200 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | CAPSULE / ORAL | 20 mg | ||
| CETOSTEARYL ALCOHOL | CETOSTEARYL ALCOHOL | 2DMT128M1S | LOTION / TOPICAL | 3627 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | TABLET, FILM COATED / ORAL | 1 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | SOLUTION / ORAL | 1867 mg | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | CAPSULE / ORAL | 2 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | LOTION / TOPICAL | 1 %w/w | ||
| ALPHA-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | TABLET / ORAL | 0.5 mg | ||
| HYDROXYETHYL CELLULOSE (140 MPA.S FOR 5% AQUEOUS SOLUTION) | HYDROXYETHYL CELLULOSE (140 MPA.S AT 5%) | 8136Y38GY5 | FILM, SOLUBLE / BUCCAL | 161 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | CREAM / TOPICAL | 385 mg | ||
| GLYCERYL MONOSTEARATE | GLYCERYL MONOSTEARATE | 230OU9XXE4 | LOTION / TOPICAL | 177 mg | ||
| HEXYLENE GLYCOL | HEXYLENE GLYCOL | KEH0A3F75J | SOLUTION / TOPICAL | 0.3 %w/w |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| EXTRASHADE Daily Defense Hydrating Sunscreen SPF 30 | AVOBENZONE, OCTINOXATE, OCTISALATE, OXYBENZONE | Extra Shade, LLC | d197dfe3-c754-4a3d-9edd-335f3fce105c | 2025-03-18 | Warnings | 42338-001-04 42338-001 42338000104 30a652e0-6e3b-e676-e063-6294a90a0434 d197dfe3-c754-4a3d-9edd-335f3fce105c |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.